Abstract: An efficient synthesis of (1R,5S)-6-(5-cyano-3-pyridinyl)-3,6-diaza-bicyclo[3.2.0]heptane A-366833, a novel potent selective neuronal nicotinic receptor (NNR) agonist, is described. The enantiomerically pure pharmacophore benzyl (1S,5S)-3,6-diaza-bicyclo[3.2.0]heptane-3-carbamate was successfully constructed from benzyl N-allyl-N-(2-hydroxyimino-ethyl)-carbamate through a convenient approach including an intramolecular [1,3]-dipolar cycloaddition, reductive ring-opening reaction, chiral resolution, and intramolecular cyclization. Subsequent N-arylation of the pharmacophore with 3-bromo-5-cyanopyridine and N-Cbz deprotection with trifluoroacetic acid furnished A-366833.
In the search for novel therapeutic compounds to safely treat both acute and chronic pain, a number of novel approaches to pain relief are currently under investigation. One of the most promising approaches is the use of selective neuronal nicotinic receptor (NNR) agonists as analgesics [1] . A diversity of NNR subtypes are widely distributed throughout the central and peripheral nervous systems. The centrally expressed α4β2 subtype is understood to be an important target involved in mediating the analgesic response elicited by NNR agonists [2] . The discovery of epibatidine, an NNR agonist with extremely potent analgesic activity [3] , fueled great interest in research directed toward identifying safe and efficacious analgesics acting through an NNR-mediated mechanism. At Abbott Laboratories, ABT-594 was discovered to possess broad-spectrum antinociceptive activity in preclinical assays of acute and chronic pain and was advanced to clinical development [4] . To further understand the NNR subtypes that mediate analgesia vs. adverse events, and to develop a second-generation NNR-based analgesic, a series of enantiopure-fused azetidines have been prepared. A-366833 was found to be a selective α4β2 agonist with broad-spectrum analgesic activity and an improved safety profile relative to ABT-594 [5] . Here, we disclose the synthesis of enantiomerically pure benzyl (1S,5S)-3,6-diaza-bicyclo[3.2.0]heptane-3-carbamate and its further application in the efficient synthesis of A-366833.
From a retrosynthetic point of view, A-366833 is straightforwardly disconnected at the C-N bond between the aromatic pyridine and fused azetidine. Upon this disconnection, the enantiomerically pure pharmacophore (1S,5S)-3,6-diaza-bicyclo[3.2.0]heptane 2 becomes the key precursor (Scheme 2). Of the many possible synthetic routes toward 2 [7] , two different approaches were initially chosen for further investigation: (a) a trans-pyrrolidine approach, constructing the azetidine ring from the trans-3,4-disubstituted pyrrolidine (4) originally reported by Jacquet et al [6] ; (b) a cis-pyrrolidine approach, assembling azetidine ring from the cis-3,4-disubstituted pyrrolidine (6).
Jacquet et al. reported a racemic synthesis of 3,6-diazabicyclo[3.2.0]heptane (13) via an intramolecular cyclization of 3,4-disubstituted N-benzyl pyrrolidine (12) (Scheme 3) [6] . This synthesis involved a multistep sequence toward the preparation of trans-3,4-disubstituted pyrrolidine (12) and required a key ring construction step via C-N bond formation through substitution of the secondary mesylate with the primary amino group. We therefore investigated this synthetic route. The mixture of trans-and cis-N-benzyl-4-hydroxymethyl-pyrrolidin-3-ol (d.r. ~2/1) (8) was prepared by the reduction of 4-oxo-pyrrolidine 7 with NaBH 4 [7] . Treatment of 8 with methanesulfonyl chloride in the presence of Et 3 N afforded trans-dimesylate 9 in 82 % yield. Displacement of the primary mesylate in 9 with NaN 3 gave azide 10. Hydrogenation of azide 11 using PtO 2 as catalyst followed by protection of the amino group in 11 with trifluoroacetic anhydride gave key intermediate 12. However, the cyclization of 12 with NaH in DMF provided 13 in low to moderate chemical yield. Elimination of the secondary mesylate in 12 was the major side reaction limiting the conversion to 13 (Scheme 3).
Substitution of the primary mesylate in 9 with a slight excess of p-methoxybenzylamine in toluene at 110 °C was also tried (Scheme 4). The reaction gave the fused azetidine 15 in 19 % yield, along with a mixture of cis/trans of disubstituted acyclic by-products 16 (38 % isolated yield). The yield for the formation of fused azetidine was improved to 46 % by the replacement of the N-benzyl protecting group in 9 with the N-Boc group (17). However, due to the limited potential of achieving a chiral synthesis of optically pure 2, further optimization of this approach was not pursued.
Our inability to achieve efficient intramolecular displacement of the secondary mesylate with either an amide anion (Scheme 3) or amine (Scheme 4) nucleophile led us to consider translocation of the reacting groups, so that ring closure involves more facile displacement of the primary mesylate by the secondary amine. This, in turn, required access to the cis-disubstituted pyrrolidine, and we specifically targeted enantiomerically pure (3S,4S)-3-amino-4-hydroxymethylpyrrolidines like 24 [8] . Ohta et al. reported that racemic benzyl 3-amino-4-hydroxymethylpyrrolidinyl carbamate could be resolved by formation of optically pure chiral salt with either (D)-or (L)-mandelic acid [8c]. To examine this protocol, racemic benzyl 3-amino-4-hydroxymethylpyrrolidinyl carbamate (22) was prepared through a twostep/one-pot sequence involving the intramolecular 1,3-dipolar cycloaddition [9] of oxime 20, followed by the reductive cleavage of isoxazolidine 21 with Zn/HOAc in overall 88 % chemical yield (Scheme 5). According to the procedures reported by Ohta, racemic amino-alcohol 22 was then treated with 1 equiv of D-mandelic acid in dry acetone at -20 °C for 48 h, and chiral salt 23 was isolated in <10 % recovery with >99 % ee. The recovery can be improved up to 30-44 % by simply pretreating 22 with excess of 2-methoxypropene. This modification also allows the chiral resolution proceed at ambient temperature without sacrificing either optical purity or chemical recovery. Hydrolysis of 23 under acidic conditions, followed by N-Boc protection under basic conditions afforded 24 in quantitative yield. Reaction of 24 with methanesulfonylchloride gave mesylate 25. As expected, the primary mesylate 25 was smoothly transformed to 2 by removal of the Boc protecting group under acidic conditions, followed by basification to liberate the nucleophilic amine, which cyclized at 60 °C to provide 2 in 96 % overall yield from 23. 
